Exogenous xylose exhibited a significant temperature-dependent regulatory effect on the furans and pyrazines formation during the degradation of dual-glycated Amadori rearrangement product of lysine (Lys), N,N-di(1-deoxy-d-xylulos-1-yl)lysine (N,N-di-Xul-Lys ARP). At 100 °C, xylose primarily enhanced the dehydration pathway of deoxypentosone. This significantly increased furans yield, while delaying lysine release by interacting with mono-glycated Lys-ARPs, thereby inhibiting the early formation of pyrazines.
View Article and Find Full Text PDFGlioblastoma (GBM) ranks among the most lethal primary tumors of the central nervous system. This is partly due to its complex intracellular metabolism and interactions with the surrounding tumor microenvironment (TME). Compelling evidence represents that altered amino acids (AAs) metabolism plays a crucial role in both areas.
View Article and Find Full Text PDFWorldwide energy needs are growing, requiring new extraction techniques for crude oil from old reservoirs. However, conventional chemicals face difficulties when exposed to harsh reservoir environments such as solubility in high saline water and heat stability under harsh reservoir environments. This study investigates the potential of newly synthesized polymeric ionic liquids (PILs) as alternative options.
View Article and Find Full Text PDFUnlabelled: Cavernous hemangiomas are venous malformations characterized by interconnected channels of abnormally dilated blood vessels having low flow of blood. Whilst venous malformations most commonly affect the head and neck region, isolated cavernous hemangiomas of the palatine tonsils are extremely rare; with only 4 cases being reported in the English Literature. We report a case of a 43-year-old female who was referred to us for the evaluation and management of a right tonsillar swelling.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
February 2025
Objective: This study was conducted in order to view the effect of eucalyptus oil in the treatment of allergic rhinitis by reducing allergic symptoms.
Data Sources: Databases including PubMed, The Cochrane Library, PLOS ONE and JSTOR were searched for articles from inception to 31st December, 2023.
Study Selections: The criteria for selection involved clinical trials in English with full text, having patients of allergic rhinitis.